BACKGROUND: Vaginal lubricants are commonly used during gynecological examinations, during sexual activities, or to alleviate vaginal dryness. Many lubricants contain potentially bacteriostatic or bactericidal agents (parabens, chlorhexidine gluconate, nonoxynol-9). Our objective was to evaluate the impact of lubricants that vary in formulation on the growth and viability of vaginal Lactobacillus species and vaginal epithelial cell (VEC) colonization in an in vitro model. METHODS: Growth curve, disk diffusion, and minimal inhibitory assays were used to determine the impact of lubricants or excipients on the growth of Lactobacillus crispatus, Lactobacillus gasseri, Lactobacillus jensenii, and Lactobacillus iners. L. crispatus strain was used in VEC colonization assays. Statistical differences were determined by analysis of variance. RESULTS: Lubricants containing chlorhexidine gluconate or nonoxynol-9 (N-9; Conceptrol, K-Y Jelly, and Surgilube) significantly inhibited Lactobacillus species growth (P < 0.05). In contrast, other clinical lubricants (E-Z Lubricating Jelly, McKesson Lubricating) and personal lubricants (Astroglide Liquid, Good Clean Love Almost Naked, K-Y Warming Jelly) did not exhibit this effect. Chlorhexidine gluconate had a detrimental effect on Lactobacillus growth and exhibited stronger antimicrobial activity compared with methylparaben and propylparaben (P < 0.0001). There were lubricants that did not induce cytotoxicity in VEC (Good Clean Love Almost Naked, E-Z Lubricating Jelly, McKesson Lubricating Jelly), but these products did substantially decrease the attachment of L. crispatus to VEC, particularly when VEC were preexposed to lubricants before inoculation with bacteria (P < 0.0001). CONCLUSIONS: This in vitro model indicates that select vaginal lubricants, particularly those with chlorhexidine gluconate, have potentially adverse effects on women's health by reducing growth and recolonization of vaginal Lactobacillus species.
BACKGROUND: Vaginal lubricants are commonly used during gynecological examinations, during sexual activities, or to alleviate vaginal dryness. Many lubricants contain potentially bacteriostatic or bactericidal agents (parabens, chlorhexidine gluconate, nonoxynol-9). Our objective was to evaluate the impact of lubricants that vary in formulation on the growth and viability of vaginal Lactobacillus species and vaginal epithelial cell (VEC) colonization in an in vitro model. METHODS: Growth curve, disk diffusion, and minimal inhibitory assays were used to determine the impact of lubricants or excipients on the growth of Lactobacillus crispatus, Lactobacillus gasseri, Lactobacillus jensenii, and Lactobacillus iners. L. crispatus strain was used in VEC colonization assays. Statistical differences were determined by analysis of variance. RESULTS: Lubricants containing chlorhexidine gluconate or nonoxynol-9 (N-9; Conceptrol, K-Y Jelly, and Surgilube) significantly inhibited Lactobacillus species growth (P < 0.05). In contrast, other clinical lubricants (E-Z Lubricating Jelly, McKesson Lubricating) and personal lubricants (Astroglide Liquid, Good Clean Love Almost Naked, K-Y Warming Jelly) did not exhibit this effect. Chlorhexidine gluconate had a detrimental effect on Lactobacillus growth and exhibited stronger antimicrobial activity compared with methylparaben and propylparaben (P < 0.0001). There were lubricants that did not induce cytotoxicity in VEC (Good Clean Love Almost Naked, E-Z Lubricating Jelly, McKesson Lubricating Jelly), but these products did substantially decrease the attachment of L. crispatus to VEC, particularly when VEC were preexposed to lubricants before inoculation with bacteria (P < 0.0001). CONCLUSIONS: This in vitro model indicates that select vaginal lubricants, particularly those with chlorhexidine gluconate, have potentially adverse effects on women's health by reducing growth and recolonization of vaginal Lactobacillus species.
Authors: Brooke E Hjelm; Alice N Berta; Cheryl A Nickerson; Charles J Arntzen; Melissa M Herbst-Kralovetz Journal: Biol Reprod Date: 2009-12-09 Impact factor: 4.285
Authors: Katie K Crean-Tate; Stephanie S Faubion; Holly J Pederson; Jennifer A Vencill; Pelin Batur Journal: Am J Obstet Gynecol Date: 2019-08-29 Impact factor: 8.661
Authors: Caroline Mitchell; Lisa E Manhart; Katherine K Thomas; Kathy Agnew; Jeanne M Marrazzo Journal: Sex Transm Dis Date: 2011-12 Impact factor: 2.830
Authors: Noureddine Halla; Isabel P Fernandes; Sandrina A Heleno; Patrícia Costa; Zahia Boucherit-Otmani; Kebir Boucherit; Alírio E Rodrigues; Isabel C F R Ferreira; Maria Filomena Barreiro Journal: Molecules Date: 2018-06-28 Impact factor: 4.411
Authors: Jacques Ravel; Pawel Gajer; Li Fu; Christine K Mauck; Sara S K Koenig; Joyce Sakamoto; Alison A Motsinger-Reif; Gustavo F Doncel; Steven L Zeichner Journal: MBio Date: 2012-12-18 Impact factor: 7.867
Authors: Susan Tuddenham; Christina A Stennett; Richard A Cone; Jacques Ravel; Andrew N Macintyre; Khalil G Ghanem; Xin He; Rebecca M Brotman Journal: BMC Infect Dis Date: 2021-09-18 Impact factor: 3.090